Notice NOT-OD-21-113 from the NIH Guide for Grants and Contracts

Notice NOT-HD-21-028 from the NIH Guide for Grants and Contracts

Notice NOT-CA-21-072 from the NIH Guide for Grants and Contracts

Notice NOT-DE-21-004 from the NIH Guide for Grants and Contracts

Notice NOT-AT-21-010 from the NIH Guide for Grants and Contracts

Notice NOT-MD-21-018 from the NIH Guide for Grants and Contracts

Notice NOT-DA-21-012 from the NIH Guide for Grants and Contracts

Notice NOT-OD-21-114 from the NIH Guide for Grants and Contracts

Notice NOT-CA-21-058 from the NIH Guide for Grants and Contracts

Competitive Salary: EMBL: About this position Continuously developed since 2002, Rfam has grown to include >3,000 families and is used by many scientists for a wide range of Hinxton, Cambridgeshire, England

Notice NOT-CA-21-053 from the NIH Guide for Grants and Contracts

They will be also involved in project monitoring and evaluation, data analysis, oversight of trainees, and dissemination of program results and will work…
From University of Wisconsin–Madison - Fri, 23 Apr 2021 06:57:59 GMT - View all Madison, WI jobs

Notice NOT-NS-21-048 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-21-234 from the NIH Guide for Grants and Contracts. (Reissue of PAR-18-490) The purpose of the NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01) is to diversify the pool of independent neuroscience research investigators by providing junior faculty with research cost support, protected research time and career stage appropriate professional development mentorship in neuroscience research. Individuals from backgrounds underrepresented in biomedical research are eligible for support under this award if they have doctoral research degrees (Ph.D. or equivalent) and are in the first 3 years of a faculty tenure track or equivalent position at the time of application. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor.

Funding Opportunity PAR-21-233 from the NIH Guide for Grants and Contracts. The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) provides support for biologic-based therapeutic discovery and development, from lead optimization through phase I clinical testing. This Funding Opportunity Announcement (FOA) supports preclinical discovery and development of potential therapeutic Biotechnology Products and Biologics including, but not limited to, large biologic macromolecules, (e.g., proteins, antibodies, and peptides), gene-based therapies (i.e., oligonucleotide- and viral-based), cell therapies, and novel emerging therapies (e.g., microbial and microbiome therapies). Applicants will collaborate with NIH-funded consultants and can augment their project with NIH contract research organizations (CROs) that specialize in manufacturing, scaling, pharmacokinetics, toxicology, and Phase I clinical testing. BPN-Biologics awardee institutions retain their assignment of IP rights and gain assignment of IP rights from the BPN-Biologics contractors (and thereby control the patent prosecution and licensing negotiations) for biotherapeutic candidates developed in this program.

Notice NOT-NS-21-060 from the NIH Guide for Grants and Contracts

Notice NOT-GM-21-037 from the NIH Guide for Grants and Contracts

Notice NOT-NS-21-056 from the NIH Guide for Grants and Contracts

Significant experience with data analysis, data science, and/or application of machine learning methodologies.
From University of Wisconsin–Madison - Fri, 23 Apr 2021 00:57:56 GMT - View all Madison, WI jobs

£45,000 - £55,000 per annum + stock option and benefits: Singular Talent: Do you want to work on cutting edge science using powerful tech and precision medicine to shape the future of health care? Oxfordshire